NLRP3 and macrophage activation syndrome: These data demonstrate that, during the development of MAS, the NLRP3 inflammasome was essential for the elevation in plasma IL-18 – a key cytokine in clinical cases of MAS – but was not a driving factor in the pathogenesis of CpG-induced MAS.